Cytomegalovirus infection in Guillain-Barré syndrome: a retrospective study in Brazil
Open Access
- 1 July 2021
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Arquivos de Neuro-Psiquiatria
- Vol. 79 (7), 607-611
- https://doi.org/10.1590/0004-282x-anp-2020-0464
Abstract
Background: Guillain-Barré syndrome (GBS) is currently the most common cause of acute flaccid paralysis worldwide. Risk factors for GBS include previous viral or bacterial infections or vaccination. Recently, an outbreak of Zika virus led to an outbreak of GBS in Latin America, mostly in Brazil, concomitant to continuous circulation of dengue virus serotypes. However, there is no study about cytomegalovirus (CMV) infection as a risk for GBS in Brazil. Objectives: In this study, we report a series of cases of GBS with the aim of determining the prevalence of CMV and the characteristics associated with the infection. Methods: A cohort of 111 GBS cases diagnosed between 2011 and 2017 in Natal, northeastern Brazil, was studied. Presence of CMV IgM antibodies was determined by means of electrochemiluminescence. The analysis was performed considering CMV infection status and the clinical outcome. Results: We found seroprevalence of 15.3% (n = 17) for CMV. CMV patients were younger (26 vs. 40; p = 0.016), with no apparent gastrointestinal (p = 0.762) or upper respiratory infections (p = 0.779) or sensory loss (p = 0.03). They presented more often with a classic GBS sensorimotor variant (p = 0.02) and with a demyelinating pattern in electrophysiological studies (p < 0.001). Conclusion: In Brazil, the clinical-epidemiological profile of GBS associated with CMV infection is similar to that described in other countries. Better understanding of the relationship between infectious processes and GBS is a key component of the research agenda and assistance strategy for global health initiatives relating to peripheral neuropathic conditions.Keywords
This publication has 19 references indexed in Scilit:
- Nodo-paranodopathy: Beyond the demyelinating and axonal classification in anti-ganglioside antibody-mediated neuropathiesClinical Neurophysiology, 2013
- Guillain-Barre Syndrome following Primary Cytomegalovirus Infection: A Prospective Cohort StudyClinical Infectious Diseases, 2011
- Anti-ganglioside antibodies and clinical outcome of patients with Guillain-Barré Syndrome in northeast BrazilActa Neurologica Scandinavica, 2003
- Electrophysiological classification of guillain‐barré syndrome: Clinical associations and outcomeAnnals of Neurology, 1998
- Cytomegalovirus infections and anti-GM2 antibodies in Guillain-Barre syndrome.Journal of Neurology, Neurosurgery & Psychiatry, 1997
- Guillain-Barré syndrome in northern China Relationship to Campylobacter jejuni infection and anti-glycolipid antibodiesBrain, 1995
- A prospective study of acute idiopathic neuropathy. II. Antecedent events.Journal of Neurology, Neurosurgery & Psychiatry, 1988
- Role of infection in Guillain-Barré syndrome: Laboratory confirmation of herpesviruses in 41 casesAnnals of Neurology, 1981
- CONTROLLED TRIAL OF PREDNISOLONE IN ACUTE POLYNEUROPATHYThe Lancet, 1978
- The Guillain‐Barré Syndrome Associated with Acquired Cytomegalovirus InfectionActa Medica Scandinavica, 1967